Australia markets close in 50 minutes

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
45.94+0.80 (+1.77%)
As of 11:29AM CST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
795,043
767,137
636,051
546,759
Cost of revenue
119,762
126,373
105,672
85,407
Gross profit
675,281
640,765
530,379
461,352
Operating expenses
Research development
53,661
50,825
48,485
39,419
Selling general and administrative
355,846
355,429
309,012
292,630
Total operating expenses
432,660
440,809
374,181
347,367
Operating income or loss
242,621
199,956
156,198
113,985
Interest expense
9,054
10,170
11,716
978.9927
Income before tax
244,241
201,061
153,702
124,994
Income tax expense
455.9957
749.2865
1,990
1,099
Income from continuing operations
243,785
200,311
151,712
123,895
Net income
243,911
200,827
151,712
123,895
Net income available to common shareholders
243,911
200,827
151,712
123,895
Basic EPS
-
1.03
0.82
0.68
Diluted EPS
-
1.03
0.82
0.68
Basic average shares
-
194,832
184,323
183,027
Diluted average shares
-
194,832
184,323
183,027
EBITDA
-
265,128
208,753
167,012